BG98813A - Терапевтични средства - Google Patents

Терапевтични средства Download PDF

Info

Publication number
BG98813A
BG98813A BG98813A BG9881394A BG98813A BG 98813 A BG98813 A BG 98813A BG 98813 A BG98813 A BG 98813A BG 9881394 A BG9881394 A BG 9881394A BG 98813 A BG98813 A BG 98813A
Authority
BG
Bulgaria
Prior art keywords
group
alkyl group
hydrogen
formula
halogen
Prior art date
Application number
BG98813A
Other languages
Bulgarian (bg)
English (en)
Inventor
Bernard Armitage
John Bowen
Malcolm Crossley
Ian Hunneyball
Bruce Leslie
Thomas Miller
Michael Spowage
Original Assignee
The Boots Company Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Boots Company Plc filed Critical The Boots Company Plc
Publication of BG98813A publication Critical patent/BG98813A/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BG98813A 1991-12-23 1994-05-31 Терапевтични средства BG98813A (bg)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB919127252A GB9127252D0 (en) 1991-12-23 1991-12-23 Therapeutic agents
PCT/EP1992/002901 WO1993013097A1 (fr) 1991-12-23 1992-12-12 Derives de naphtyridine antirhumatismaux
CN93109454A CN1096784A (zh) 1991-12-23 1993-06-22 含取代4(5)-氨基-1,8-二氨杂萘的治疗剂

Publications (1)

Publication Number Publication Date
BG98813A true BG98813A (bg) 1995-05-31

Family

ID=36822317

Family Applications (1)

Application Number Title Priority Date Filing Date
BG98813A BG98813A (bg) 1991-12-23 1994-05-31 Терапевтични средства

Country Status (22)

Country Link
US (1) US5464781A (fr)
EP (1) EP0618916B1 (fr)
JP (1) JP2527917B2 (fr)
CN (1) CN1096784A (fr)
AT (1) ATE171452T1 (fr)
AU (1) AU656832B2 (fr)
BG (1) BG98813A (fr)
CA (1) CA2125858A1 (fr)
CZ (1) CZ153594A3 (fr)
DE (1) DE69227125T2 (fr)
FI (1) FI943019A0 (fr)
GB (1) GB9127252D0 (fr)
HR (1) HRP921455A2 (fr)
HU (1) HUT66971A (fr)
IL (1) IL104169A0 (fr)
IN (1) IN174405B (fr)
MX (1) MX9207494A (fr)
NO (1) NO942376L (fr)
NZ (1) NZ246156A (fr)
SI (1) SI9200408A (fr)
SK (1) SK75094A3 (fr)
WO (1) WO1993013097A1 (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9312891D0 (en) * 1993-06-22 1993-08-04 Boots Co Plc Therapeutic agents
GB9318931D0 (en) * 1993-09-14 1993-10-27 Boots Co Plc Therapeutic agents
GB9420168D0 (en) * 1994-10-06 1994-11-23 Boots Co Plc Therapeutic agents
AR004010A1 (es) 1995-10-11 1998-09-30 Glaxo Group Ltd Compuestos heterociclicos
ATE300521T1 (de) 1996-09-25 2005-08-15 Astrazeneca Ab Chinolin-derivate die den effekt von wachstumsfaktoren wie vegf vezögern
RS49779B (sr) 1998-01-12 2008-06-05 Glaxo Group Limited, Biciklična heteroaromatična jedinjenja kao inhibitori protein tirozin kinaze
US6166069A (en) * 1998-05-12 2000-12-26 American Home Products Corporation Phenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
ATE377597T1 (de) 1999-07-09 2007-11-15 Glaxo Group Ltd Anilinochinazoline als protein-tyrosin- kinasehemmer
US6933299B1 (en) 1999-07-09 2005-08-23 Smithkline Beecham Corporation Anilinoquinazolines as protein tyrosine kinase inhibitors
US7160889B2 (en) 2000-04-07 2007-01-09 Astrazeneca Ab Quinazoline compounds
US6534656B2 (en) * 2001-05-31 2003-03-18 North Carolina State University Short synthesis of pyridine-based pharmaceutical intermediates
JP2003329989A (ja) * 2002-03-06 2003-11-19 Nippon Telegr & Teleph Corp <Ntt> 光送信装置
GB0230018D0 (en) 2002-12-23 2003-01-29 Syngenta Ltd Fungicides
WO2006074147A2 (fr) 2005-01-03 2006-07-13 Myriad Genetics, Inc. Composes et utilisation therapeutique associee
EP1660092A2 (fr) 2003-07-03 2006-05-31 Myriad Genetics, Inc. 4-arylamino-quinazolines comme activateurs de caspases et inducteurs d'apoptose
US8309562B2 (en) * 2003-07-03 2012-11-13 Myrexis, Inc. Compounds and therapeutical use thereof
BRPI0418102A (pt) 2003-12-23 2007-04-27 Pfizer derivados de quinolina
US8258145B2 (en) * 2005-01-03 2012-09-04 Myrexis, Inc. Method of treating brain cancer
WO2007076034A2 (fr) * 2005-12-21 2007-07-05 Abbott Laboratories Composes antiviraux
CN102702194A (zh) * 2005-12-21 2012-10-03 雅培制药有限公司 抗病毒化合物
TW200738707A (en) * 2005-12-21 2007-10-16 Abbott Lab Anti-viral compounds
WO2007081517A2 (fr) 2005-12-21 2007-07-19 Abbott Laboratories Composes anti-viraux
EP2345652A1 (fr) 2005-12-21 2011-07-20 Abbott Laboratories Composées antivirales
TWI399380B (zh) 2006-12-20 2013-06-21 Abbott Lab 抗病毒化合物
EP2291376A2 (fr) * 2008-07-03 2011-03-09 Merck Patent GmbH Naphtyridininones en tant qu inhibiteurs d aurora kinase
US8415333B2 (en) 2009-02-24 2013-04-09 Respiratorious Ab Bronchodilating diazaheteroaryls
WO2011063398A1 (fr) * 2009-11-23 2011-05-26 Cylene Pharamaceuticals, Inc. Polymorphes et sels d'un inhibiteur de kinase
SG10201507846YA (en) 2010-04-02 2015-10-29 Senomyx Inc Sweet flavor modifier

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4466965A (en) * 1982-07-26 1984-08-21 American Hospital Supply Corporation Phthalazine compounds, compositions and use
NZ213986A (en) * 1984-10-30 1989-07-27 Usv Pharma Corp Heterocyclic or aromatic compounds, and pharmaceutical compositions containing such
EP0222839A4 (fr) * 1985-05-17 1988-11-09 Univ Australian Composes antipaludiques.
JPS6368568A (ja) * 1986-09-10 1988-03-28 Otsuka Pharmaceut Factory Inc ｐ−アミノフエノ−ル誘導体
DE3644825A1 (de) * 1986-12-31 1988-07-14 Basf Ag Substituierte 1,8-naphthyridin-derivate und diese enthaltende fungizide
JPH07116187B2 (ja) * 1987-07-22 1995-12-13 シェリング・コーポレーション 二環式化合物、それらを薬剤として使用すること、それらの製法、およびそれらの製造に有用な中間体
GB8804443D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
US4978661A (en) * 1988-09-29 1990-12-18 Innocenzo Caruso Use of 6-halo-4-quinolone compounds and pharmaceutical compositions thereof for the preparation of a medicament for the therapeutical application in rheumatoid arthritis
GR900100380A (el) * 1989-05-20 1991-10-10 Fisons Plc Μέ?οδος παρασκευής αντι-φλεγμονωδών παραγώγων αμινοφενόλης.
AU634561B2 (en) * 1989-07-27 1993-02-25 Eli Lilly And Company Naphthyridine derivatives
JP2988739B2 (ja) * 1990-04-16 1999-12-13 協和醗酵工業株式会社 １，８−ナフチリジン−２−オン誘導体
JP3157077B2 (ja) * 1994-02-16 2001-04-16 内山工業株式会社 ベアリングシール

Also Published As

Publication number Publication date
HU9401877D0 (en) 1994-09-28
FI943019A (fi) 1994-06-22
IN174405B (fr) 1994-11-26
CN1096784A (zh) 1994-12-28
NZ246156A (en) 1996-01-26
DE69227125D1 (de) 1998-10-29
FI943019A0 (fi) 1994-06-22
US5464781A (en) 1995-11-07
GB9127252D0 (en) 1992-02-19
CZ153594A3 (en) 1995-02-15
CA2125858A1 (fr) 1993-07-08
DE69227125T2 (de) 1999-02-18
JPH07502280A (ja) 1995-03-09
HUT66971A (en) 1995-01-30
ATE171452T1 (de) 1998-10-15
SK75094A3 (en) 1995-04-12
EP0618916A1 (fr) 1994-10-12
AU3158793A (en) 1993-07-28
HRP921455A2 (en) 1994-12-31
NO942376L (no) 1994-06-22
WO1993013097A1 (fr) 1993-07-08
IL104169A0 (en) 1993-05-13
SI9200408A (en) 1993-09-30
AU656832B2 (en) 1995-02-16
JP2527917B2 (ja) 1996-08-28
NO942376D0 (fr) 1994-06-22
EP0618916B1 (fr) 1998-09-23
MX9207494A (es) 1993-07-01

Similar Documents

Publication Publication Date Title
EP0618916B1 (fr) Derives de naphtyridine antirhumatismaux
US5780482A (en) Condensed 4-aminopyridines with antirheumatic activity
JP7065951B2 (ja) Ｐａｄ阻害剤としての複素環式化合物
JPH0327380A (ja) １ｈ―イミダゾ〔４，５―ｃ〕キノリン―４―アミン類
JPH10506906A (ja) ナフチリジノン誘導体
BG61367B2 (bg) Циклоалкилтриазоли
CA2104883A1 (fr) Derives d&#39;acide thienyl ou pyrrolyl carboxyliques, leur preparation et medicaments les contenant
RO117917B1 (ro) Derivati de imidazopiridina, procedee de obtinere si produs medicamentos
CZ374692A3 (en) Proteolytic enzymes inhibitors based on saccharin derivatives
CA3034785A1 (fr) Inhibiteur de pde4
RU2161154C2 (ru) Новые производные пиридоновых карбоновых кислот, способ и промежуточные для их получения, фармацевтическая композиция и способ лечения инфекционных заболеваний
JPH0311067A (ja) 興奮性アミノ酸拮抗剤
EP1776369B1 (fr) Carboxamides de thiénopyridone et leur utilisation médicale
WO1995030676A1 (fr) Antirhumatismaux a base de 1-alcoyle-4-hydroxy-3-(thien-3-yl)1,8-naphtyridin-2(1h)-ones
EP0784623B1 (fr) Derives de naphtyridine
JPS61205275A (ja) 新規の８‐チオテトラヒドロキノリン誘導体及びそれらの塩
JPS6229585A (ja) エーテル化若しくはエステル化しうるジヒドロキシ基により位置２で置換された４―ｏｈキノリンカルボン酸の新規の誘導体、その製造方法、及び医薬としてのその使用
CN104837827A (zh) 吡啶酮衍生物及其在治疗结核病中的用途
WO1995007909A1 (fr) Carboxylates d&#39;alkyl-1-alkyl-4-hydroxy-2-oxo-1,8-naphtyridine-3 en tant qu&#39;agents antirhumatismaux
JPS63154682A (ja) ピロール誘導体類、それらの製造およびそれらを含有する製薬学的組成物
JPH08225531A (ja) キノリンまたはキナゾリン誘導体を含んでなる医薬およびそれに用いる新規誘導体
EP0011854A1 (fr) Dérivés de l&#39;acide 4-(2&#39;-pyridylamino)phényl-acétique, procédé pour leur préparation, compositions pharmaceutiques contenant ces composés et leur utilisation
CN115385846A (zh) 一种吲哚类化合物、其制备方法及应用
JPH10503782A (ja) 新規な５Ｈ−チアゾロ［３，２−ａ］ピリミジン−５−オン誘導体
JPH01265070A (ja) カルバモイル−２−ピロリジノン化合物